Implementation of proven interventions in general medical inpatients: Development and evaluation of a new quality indicator for drug therapy

Quality and Safety in Health Care

Volumn 17, Issue 4, 2008, Pages 269-274

  Huang, C ^a   Loewen, P ^a,b   Pelletier, T ^a   Slater, J ^a,b   Chung, M ^a,b  

^a VANCOUVER COASTAL HEALTH   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ANALYSIS OF VARIANCE; ARTICLE; CANADA; COMMUNITY HOSPITAL; DRUG THERAPY; EVALUATION; FEASIBILITY STUDY; FEMALE; HEALTH CARE QUALITY; HOSPITAL; HUMAN; MALE; PRACTICE GUIDELINE; RETROSPECTIVE STUDY; STATISTICAL MODEL; STATISTICS;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BRITISH COLUMBIA; DRUG THERAPY; FEASIBILITY STUDIES; FEMALE; GUIDELINE ADHERENCE; HOSPITALS, COMMUNITY; HOSPITALS, URBAN; HUMANS; LINEAR MODELS; MALE; PRACTICE GUIDELINES AS TOPIC; QUALITY INDICATORS, HEALTH CARE; RETROSPECTIVE STUDIES;

EID: 58149134516     PISSN: 14753898     EISSN: 14753901     Source Type: Journal    
DOI: 10.1136/qshc.2007.023416     Document Type: Article

References (59)

1. Marciniak TA, Ellerbeck EF, Radford MJ, et al. Improving the quality of care for medicare patients with acute myocardial infarction: Results from the cooperative cardiovascular project. JAMA 1998;279:1351-7.
2. Kong GK, Belman MJ, Weingarten S. Reducing length of stay for patients hospitalized with exacerbation of COPD by using a practice guideline. Chast 1997;111:89-94.
3. Mazzuca SA, Vinicor F, Cohen SJ, et al. The diabetes education study: A controlled trial of the effects of intensive instruction of internal medicine residents on the management of diabetes mellitus. J Gan Intarn Mad 1988;3:1-8.
4. Landefeld CS, Anderson PA. Guideline-based consultation to prevent anticoagulant-related bleeding. A randomized, controlled trial in a teaching hospital. Ann Intarn Mad 1992;15;116:829-37.
5. Weingarten S, Riedinger M, Conner L, et al. Reducing lengths of stay in the coronary care unit with a practice guideline for patients with congestive heart failure. Insights from a controlled clinical trial. Mad Cara 1994;32:1232-43.
6. Forster AJ, Murff HJ, Peterson JF, et al. The incidence and severity of adverse events affecting patients after discharge from the hospital. Ann Intarn Mad 2003;138:161-7.
7. Anon. Hospital quality initiative overview. Available from: http://www.cms.hhs.gov/quality/hospital/overview.pdf (accessed 2 Sep 2005).
8. Anon. Hospital compare. Available from: http://www. hospitalcompare.hhs.gov/ (accessed 2 Sep 2005).
9. Baker GR, Norton PG, Flintoft V, at al. The Canadian adverse events study: The incidence of adverse events among hospital patients in Canada. CMAJ 2004;170:1678-86.
10. Rojas-Fernandez CH, Kephart GC, Sketris IS, at al. Underuse of acetylsalicylic acid in individuals with myocardial infarction, ischemic heart disease or stroke: Data from the 1995 population-based Nova Scotia health survey. Can J Cardiol 1999;15:291-6.
11. Papaioannou A, Giangregorio L, Kvern B, at al. The osteoporosis care gap in Canada. BMC Musculoskalat Disord 2004;5:11.
12. Cox JL, Ramer SA, Lee DS, at al. Pharmacological treatment of congestive heart failure in Canada: A description of care in five provinces. Can J Cardiol 2005;15;21:337-43.
13. Hanlon JT, Schmader KE, Ruby CM, et al. Suboptimal prescribing in older inpatients and outpatients. J Am Gariatr Soc 2001;49:200-9.
14. Forster AJ, Clark HD, Menard A, atal. Adverse events among medical patients after discharge from hospital. CMAJ 2004;170:345- 9.
15. Muhlestein JB, Horne BD, Bair TL, et al. Usefulness of in-hospital prescription of statin agents after angiographic diagnosis of coronary artery disease in improving continued compliance and reduced mortality. Am J Cardiol 2001;87:257-61.
16. Follin SL, Black JN, McDermott MT. Lack of diagnosis and treatment of osteoporosis in men and women after hip fracture. Pharmacotharapy 2003;23:190-8.
17. Kiebzak GM, Beinart GA, Perser K, et al. Undertreatment of osteoporosis in men with hip fracture. Arch Intarn Mad 2002;162:2217-22.
18. Panneman MJ, Lips P, Sen SS, at al. Undertreatment with anti-osteoporotic drugs after hospitalization for fracture. Ostaoporos Int 2004;15:120-4.
19. Simonelli C, Chen YT, Morancey J, et al. Evaluation and management of osteoporosis following hospitalization for low-impact fracture. J Gan Intarn Mad 2003;18:17-22.
20. Whincup PH, Emberson JR, Lennon L, et al. Low prevalence of lipid lowering drug use in older men with established coronary heart disease. Haart 2002;88:25-9.
21. Miller M, Byington R, Hunninghake D, et al. Sex bias and underutilization of lipid-lowering therapy in patients with coronary artery disease at academic medical centers in the United States and Canada. prospective randomized evaluation of the vascular effects of norvasc trial (PREVENT) investigators. Arch Intarn Mad 2000;160:343-7.
22. Fonarow GC, Gawlinski A, Moughrabi S, et al. Improved treatment of coronary heart disease by implementation of a cardiac hospitalization atherosclerosis management program (CHAMP). Am J Cardiol 2001;87:819-22.
23. Ghosh S, Ziesmer V, Aronow WS. Underutilization of aspirin, beta blockers, angiotensin-converting enzyme inhibitors, and lipid-lowering drugs and overutilization of calcium channel blockers in older persons with coronary artery disease in an academic nursing home. J Garontol A Biol Sci Mad Sci 2002;57:M398-400.
24. Choudhry NK, Soumerai SB, Normand SL, at al. Warfarin prescribing in atrial fibrillation: The impact of physician, patient, and hospital characteristics. Am J Mad 2006;119:607-15.
25. Luzier AB, DiTusa L. Underutilization of ACE inhibitors in heart failure. Pharmacotharapy 1999;19:1296-307.
26. Lane CJ, Bronskill SE, Sykora K, at al. Potentially inappropriate prescribing in Ontario community-dwelling older adults and nursing home residents. J Am Gariatr Soc 2004;52:861-6.
27. Caterino JM, Emond JA, Camargo CA Jr. Inappropriate medication administration to the acutely ill elderly: A nationwide emergency department study, 1992-2000. J Am Gariatr Soc 2004;52:1847-55.
28. Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly. an update. Arch Intarn Mad 1997;157:1531-6.
29. Beers MH, Fingold SF, Ouslander JG, et al. Characteristics and quality of prescribing by doctors practicing in nursing homes. J Am Gariatr Soc 1993;41:802-7.
30. Beers MH, Ouslander JG, Rollingher I, et al. Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA division of geriatric medicine. Arch Intarn Mad 1991;151:1825-32.
31. Fialova D, Topinkova E, Gambassi G, et al. Potentially inappropriate medication use among elderly home care patients in Europe. JAMA 2005;16;293:1348-58.
32. Hayward RA, Asch SM, Hogan MM, at al. Sins of omission: Getting too little medical care may be the greatest threat to patient safety. Journal of Ganaral Intarnal Madicina 2005;20:686-91.
33. Johnson D, Jin Y, Quan H, at al. Beta-blockers and angiotensin-converting enzyme inhibitors/receptor blockers prescriptions after hospital discharge for heart failure are associated with decreased mortality in Alberta, Canada. J Am Coll Cardiol 2003;42:1438-45.
34. Schwiesow SJ, Nappi JM, Ragucci KR. Assessment of compliance with lipid guidelines in an academic medical center. Ann Pharmacothar 2006;40:27-31.
35. Krousel-Wood M, Hyre A, Muntner P, at al. Methods to improve medication adherence in patients with hypertension: Current status and future directions. Curr Opin Cardiol 2005;20:296-300.
36. Laine C, Davidoff F. Patient-centered medicine. A professional evolution. JAMA 1996;10;275:152-6.
37. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990;47:533-43.
38. Kassirer JP. The quality of care and the quality of measuring it. N Engl J Mad 1993;329:1263-5.
39. Klinke JA, Johnson JA, Guirguis LM, et al. Underuse of aspirin in type 2 diabetes mellitus: Prevalence and correlates of therapy in rural Canada. Clin Thar 2004;26:439-46.
40. Massing MW, Sueta CA, Chowdhury M, et al. Lipid management among coronary artery disease patients with diabetes mellitus or advanced age. Am J Cardiol 2001;87:646-9.
41. Anon. The Canadian patient safety dictionary. Available from: http://rcpsc.medical.org/publications/PatientSafetyDictionary-e.pdf (accessed 2 Sep 2005).
42. Brennan TA, Leape LL, Laird NM, et al. Incidence of adverse events and negligence in hospitalized patients: Results of the Harvard medical practice study I. 1991. Qual Saf Health Cara 2004;13:145-51.
43. Chassin MR, Galvin RW. The urgent need to improve health care quality. Institute of Medicine National Roundtable on Health Care Quality. JAMA 1998;280:1000-5.
44. SPSS. [computer program] Version 11. Chicago: SPSS, 2001.
45. Anon. Hospital compare. Available from: http://www. hospitalcompare.hhs.gov (accessed 6 Jun 2006).
46. Lancaster T, Stead LF. Physician advice for smoking cessation. Cochrane Database Syst Rav 1996;(3):CD000165.
47. Kessner DM, Kalk CE, Singer J. Assessing health quality-the case for tracers. N Engl J Mad 1973;288:189-93.
48. Naylor CD, Guyatt GH. Users' guides to the medical literature. XI. How to use an article about a clinical utilisation review. JAMA 1996;275:1435-9.
49. Overhage JM, Tierney WM, McDonald CJ. Computer reminders to implement preventive care guidelines for hospitalized patients. Arch Intarn Mad 1996;156:1551-6.
50. Higashi T, Shekelle PG, Solomon DH, et al. The quality of pharmacologic care for vulnerable older patients. Ann Intarn Mad 2004;140:714-20.
51. Grimshaw JM, Thomas RE, MacLennan G, et al. Effectiveness and efficiency of guideline dissemination and implementation strategies. Haalth Tachnol Assass 2004;8:1-72.
52. Werner RM, BradlowET. Relationship between Medicare's Hospital Compare performance measures and mortality rates. JAMA 2006;296:2694-702.
53. Yusuf S, Sleight P, Pogue J, et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. the heart outcomes prevention evaluation study investigators. N Engl J Mad 2000;342:145-53.
54. Gibbons RJ, Abrams J, Chatterjee K, et al. American College of Cardiology. American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). ACC/AHA 2002 guideline update for the management of patients with chronic stable angina-summary article: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Chronic Stable Angina). J Am Coll Cardiol 2003;41:159-68.
55. Sacco RL, Adams R, Albers G, et al. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: A statement for healthcare professionals from the American heart Association/American Stroke Association Council on Stroke: Co-sponsored by the Council on Cardiovascular Radiology and Intervention: The American Academy of Neurology affirms the value of this guideline. Stroka 2006;37:577-617.
56. Singer DE, Albers GW, Dalen JE, et al. Antithrombotic therapy in atrial fibrillation: The seventh ACCP conference on antithrombotic and thrombolytic therapy. Chast 2004;126(Suppl):429-56S.
57. American Diabetes Association. Standards of medical care in diabetes. Diabatas Cara 2004;27(Suppl 1):15-35S.
58. Brown JP, Josse RG, Scientific Advisory Council of the Osteoporosis Society of Canada. 2002 Clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ 2002;167(Suppl):1-34S.
59. Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: A report of the American college of Cardiology/American heart association task force on practice guidelines. (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). Circulation 2005;112:e154-235.